Karen M. Boezi

NaviNet, Inc. provides software for communication between healthcare providers. It offers NaviNet open provider portal, open advance referrals, document exchange and value based network applications. The company was founded in 1998 by Robert Chin, Thomas G. Morrison, William R. Cowen, Bradley J. Waugh and Jeffrey Daly and is headquartered in Boston, MA.

Part of University of California, California Institute For Quantitative Biosciences is a biotech company that offers internships to UC students through its state-funded Qwest internship program. The private company is based in San Francisco, CA and was founded in 2000. The program places students with Bakar Labs tenant companies for work experience, and four of its first cohort have already received full-time job offers from their hosts. The company conducts proof-of-concept experiments in a mouse model of ALS and offers mentoring programs to early-stage companies.

Acrigen Biosciences, Inc. operates as a early-stage life science gene editing company. The company was founded by Joseph Bondy-Denomy in 2019 and is headquartered in Kensington, CA.

Leptos is developing a proprietary neuromodulation therapy for chronic obesity. The treatment, delivered via a pacemaker-type device, involves electrical activation of a specific nerve in the autonomic nervous system. They believe that this therapy may offer an effective minimally invasive, reversible surgical option for people suffering from chronic obesity. As yet, the Leptos therapy is not approved for sale in the United States and is limited to investigational use.

Thomas, McNerney & Partners LLC (Thomas McNerney & Partner) is a venture capital subsidiary of the Coral Group Inc founded in 1998. The firm is headquartered in Minneapolis, Minnesota.

Coral Group, Inc. is a venture capital firm. It offers telecom, Internet and media content, real time data, IoT sectors, mobile, security, ecommerce, and cloud services. The company was founded by Yuval Almog in 1990 and is headquarterd in Minneapolis, MN.

Warburg Pincus LLC (Warburg Pincus) is a private equity subsidiary of Warburg Pincus & Company US LLC founded in 1966. The firm is headquartered in New York.

Redwood Bioscience Inc. develops precision protein-chemical engineering technology to produce the next-generation of antibody-drug conjugates and other semi-synthetic biotherapeutics. It employs natural post translational modifications found in human cells to site specifically create one or more aldehyde tags on protein molecules, including monoclonal antibodies. The firm's platform is enabled with precision chemistries, payload positioning and defined stoichiometry of payload protein ratios. The company was founded by Carolyn R. Bertozzi, Mike Blank and David Rabuka in 2008 and is headquartered in Emeryville, CA.